SEC Form 4: Valliant John sold $29,324 worth of shares (3,800 units at $7.72) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 363,160 units

ByQuantisnow·Wall Street's wire, on your screen.

FUSN· Fusion Pharmaceuticals Inc.

Health Care

Original source

SEC Form 4: Valliant John sold $29,324 worth of shares (3,800 units at $7.72) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 363,160 units | Quantisnow